Lynda Sarah Cranston serves as Executive at DelMar Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Lynda Sarah Cranston has executed 18 insider transactions totaling $7.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 30, 2020 involved transacting 8 shares valued at $0.
Lynda Sarah Cranston currently holds 332 shares of DelMar Pharmaceuticals, Inc. (DMPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lynda Sarah Cranston has been a net buyer of DMPI stock. They have purchased $7.5K and sold $0 worth of shares.
Lynda Sarah Cranston's most recent insider trade was on Jun 30, 2020, when they sold 8 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 31, 2019 | DMPI | $0 | Other | 8 | $N/A | Discretionary |
| Sep 30, 2019 | DMPI | $0 | Other | 8 | $N/A | Discretionary |
| Jun 28, 2019 | DMPI | $0 | Other | 8 | $N/A | Discretionary |
| Mar 29, 2019 | DMPI | $35 | Other | 71 | $0.49 | Discretionary |
| Dec 31, 2018 | DMPI | $24 | Other | 71 | $0.34 | Discretionary |
| Sep 28, 2018 | DMPI | $227 | Other | 71 | $3.20 | Discretionary |
| Jun 29, 2018 | DMPI | $227 | Other | 71 | $3.20 | Discretionary |
| Mar 30, 2018 | DMPI | $227 | Other | 71 | $3.20 | Discretionary |
| Dec 31, 2017 | DMPI | $227 | Other | 71 | $3.20 | Discretionary |
| Sep 29, 2017 | DMPI | $227 | Other | 71 | $3.20 | Discretionary |
| Jun 30, 2017 | DMPI | $227 | Other | 71 | $3.20 | Discretionary |
| Jun 26, 2017 | DMPI | $7.5K | Purchase | 2,083 | $3.60 | Discretionary |
| Mar 31, 2017 | DMPI | $227 | Other | 71 | $3.20 | Discretionary |
| Dec 31, 2016 | DMPI | $227 | Other | 71 | $3.20 | Discretionary |
| Oct 3, 2016 | DMPI | $227 | Other | 71 | $3.20 | Discretionary |
| Jul 18, 2016 | DMPI | $154 | Other | 48 | $3.20 | Discretionary |